Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity

BACKGROUND: Multidrug-resistant (MDR) tuberculosis has low treatment success rates, and new treatment strategies are needed. We explored whether treatment with active vitamin D(3) (vitD) and phenylbutyrate (PBA) could improve conventional chemotherapy by enhancing immune-mediated eradication of Myco...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao Muvva, Jagadeeswara, Ahmed, Sultan, Rekha, Rokeya Sultana, Kalsum, Sadaf, Groenheit, Ramona, Schön, Thomas, Agerberth, Birgitta, Bergman, Peter, Brighenti, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280489/
https://www.ncbi.nlm.nih.gov/pubmed/33606878
http://dx.doi.org/10.1093/infdis/jiab100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280489/
https://www.ncbi.nlm.nih.gov/pubmed/33606878
http://dx.doi.org/10.1093/infdis/jiab100

Ejemplares similares